Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Raman

Showing results (421-430 of 455) with videos related to

Pageof 46
Sort By:
Journal of Clinical Medicine|April 29, 2020
Validation of Hyponatremia as a Prognostic Predictor in Multiregional Upper Tract Urothelial CarcinomaHsin-Chih Yeh, Ching-Chia Li, Sheng-Chen Wen, et al.
World Journal of Urology|April 23, 2020
Interethnic differences in the impact of body mass index on upper tract urothelial carcinoma following radical nephroureterectomyHsin-Chih Yeh, Ching-Chia Li, Tsu-Ming Chien, et al.
European Urology|June 30, 2009
The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?Marco Roscigno, Shahrokh F Shariat, Vitaly Margulis, et al.
World Journal of Urology|December 15, 2015
Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intentAurélie Mbeutcha, Ilaria Lucca, Vitaly Margulis, et al.
The Journal of Urology|April 18, 2009
Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomyMarco Roscigno, Shahrokh F Shariat, Vitaly Margulis, et al.
The Journal of Urology|July 3, 2017
Prognostic Value of PD-1 and PD-L1 Expression in Patients with High Grade Upper Tract Urothelial CarcinomaLaura-Maria Krabbe, Barbara Heitplatz, Sina Preuss, et al.
European Urology Oncology|December 18, 2024
Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin-Unresponsive Non-Muscle Invasive Bladder CancerJacob Taylor, Ashish M Kamat, Drupad Annapureddy, et al.
BJU International|April 22, 2011
Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international studyKazumasa Matsumoto, Giacomo Novara, Amit Gupta, et al.
European Urology|July 22, 2009
Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomyJay D Raman, Casey K Ng, Douglas S Scherr, et al.
The Journal of Urology|August 26, 2021
Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm TrialK Kent Chevli, Neal D Shore, Andrew Trainer, et al.
Pageof 46

Showing results (421-430 of 455) with videos related to

Sort By:
Pageof 46
Journal of Clinical Medicine|April 29, 2020
Validation of Hyponatremia as a Prognostic Predictor in Multiregional Upper Tract Urothelial CarcinomaHsin-Chih Yeh, Ching-Chia Li, Sheng-Chen Wen, et al.
World Journal of Urology|April 23, 2020
Interethnic differences in the impact of body mass index on upper tract urothelial carcinoma following radical nephroureterectomyHsin-Chih Yeh, Ching-Chia Li, Tsu-Ming Chien, et al.
European Urology|June 30, 2009
The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?Marco Roscigno, Shahrokh F Shariat, Vitaly Margulis, et al.
World Journal of Urology|December 15, 2015
Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intentAurélie Mbeutcha, Ilaria Lucca, Vitaly Margulis, et al.
The Journal of Urology|April 18, 2009
Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomyMarco Roscigno, Shahrokh F Shariat, Vitaly Margulis, et al.
The Journal of Urology|July 3, 2017
Prognostic Value of PD-1 and PD-L1 Expression in Patients with High Grade Upper Tract Urothelial CarcinomaLaura-Maria Krabbe, Barbara Heitplatz, Sina Preuss, et al.
European Urology Oncology|December 18, 2024
Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin-Unresponsive Non-Muscle Invasive Bladder CancerJacob Taylor, Ashish M Kamat, Drupad Annapureddy, et al.
BJU International|April 22, 2011
Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international studyKazumasa Matsumoto, Giacomo Novara, Amit Gupta, et al.
European Urology|July 22, 2009
Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomyJay D Raman, Casey K Ng, Douglas S Scherr, et al.
The Journal of Urology|August 26, 2021
Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm TrialK Kent Chevli, Neal D Shore, Andrew Trainer, et al.
Pageof 46